spot_img
Friday, May 27, 2022
More
    HomeHealthBiogen sells stake in Samsung venture for $2.3 billion

    Biogen sells stake in Samsung venture for $2.3 billion

    -

    [ad_1]

    Biogen is promoting its stake in a pharmaceutical three way partnership with the South Korean conglomerate Samsung for $2.3 billion, the corporate mentioned Thursday, bolstering the drugmaker’s steadiness sheet.

    Beneath the settlement, Samsung Biologics is buying Biogen’s possession in Samsung Bioepis, which manufactures off-patent variations of biologic medicines referred to as biosimilars. Biogen will get $1 billion in money as soon as the deal closes, adopted by $1.25 billion paid out over two years. The three way partnership, based in 2012, has six accepted biosimilars and 5 extra in improvement.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED



    [ad_2]

    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,335FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts